Cargando…

Pemphigus vulgaris as an immune-related adverse event in recurrent metastatic esophageal squamous cell carcinoma treated with ipilimumab plus nivolumab: a case report and literature review

Ipilimumab plus nivolumab therapy is approved for patients with unresectable advanced esophageal squamous cell carcinoma (ESCC). Although a combination of immune checkpoint inhibitors (ICIs), compared to conventional chemotherapy, can improve overall survival in patients with advanced ESCC, this inc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakamura, Hajime, Shionoya, Aika, Arihara, Yohei, Hayasaka, Naotaka, Kubo, Tomohiro, Usami, Makoto, Sugita, Shintaro, Uhara, Hisashi, Takada, Kohichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518453/ https://www.ncbi.nlm.nih.gov/pubmed/37753079 http://dx.doi.org/10.3389/fimmu.2023.1259071

Ejemplares similares

Successful mycophenolate mofetil treatment of a patient with severe steroid‐refractory hepatitis evoked by nivolumab plus ipilimumab treatment for relapsed bladder cancer
por: Omori, Ginji, et al.
Publicado: (2020)

Complete Response to Eribulin in a Patient with Unresectable Liposarcoma: A Case Report and Implications of New Biomarkers
por: Nakamura, Hajime, et al.
Publicado: (2022)

Trastuzumab-Based Combination Chemotherapy in Patients with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Carcinoma ex Pleomorphic Adenoma
por: Arihara, Yohei, et al.
Publicado: (2018)

Pneumothorax as an Adverse Event in Patients with Lung Metastasis of Soft Tissue Sarcoma under Eribulin Treatment
por: Takada, Kohichi, et al.
Publicado: (2019)

Combination of eribulin plus AKT inhibitor evokes synergistic cytotoxicity in soft tissue sarcoma cells
por: Hayasaka, Naotaka, et al.
Publicado: (2019)

Recurrence of Pemphigus Vulgaris Under Nivolumab Therapy
por: Krammer, Sebastian, et al.
Publicado: (2019)

Activated p53 with Histone Deacetylase Inhibitor Enhances L-Fucose-Mediated Drug Delivery through Induction of Fucosyltransferase 8 Expression in Hepatocellular Carcinoma Cells
por: Okagawa, Yutaka, et al.
Publicado: (2016)

Targeting STEAP1 as an anticancer strategy
por: Nakamura, Hajime, et al.
Publicado: (2023)

Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma
por: Wolchok, Jedd D., et al.
Publicado: (2022)

Small molecule CP-31398 induces reactive oxygen species-dependent apoptosis in human multiple myeloma
por: Arihara, Yohei, et al.
Publicado: (2017)

Nivolumab plus ipilimumab in the treatment of advanced melanoma
por: Tsai, Katy K., et al.
Publicado: (2015)

The iron chelator deferasirox induces apoptosis by targeting oncogenic Pyk2/β-catenin signaling in human multiple myeloma
por: Kamihara, Yusuke, et al.
Publicado: (2016)

Primary resistance to nivolumab plus ipilimumab therapy in patients with metastatic renal cell carcinoma
por: Numakura, Kazuyuki, et al.
Publicado: (2023)

Pemphigus vulgaris
por: Tamgadge, Sandhya, et al.
Publicado: (2011)

Pemphigus vulgaris
por: Porro, Adriana Maria, et al.
Publicado: (2019)

Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab
por: Chapman, Paul B, et al.
Publicado: (2021)

Six-transmembrane epithelial antigen of the prostate 1 accelerates cell proliferation by targeting c-Myc in liver cancer cells
por: Iijima, Kazutaka, et al.
Publicado: (2021)

Final analysis of a phase II study of nivolumab in combination with ipilimumab for unresectable chemotherapy‐naive advanced melanoma
por: Namikawa, Kenjiro, et al.
Publicado: (2020)

Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer
por: Shitara, Kohei, et al.
Publicado: (2022)

Halo formations around senile hemangiomas in diffuse plane normolipemic xanthomatosis associated with monoclonal gammopathy
por: Hida, Tokimasa, et al.
Publicado: (2018)

Metastatic mucinous tubular and spindle cell carcinoma of the kidney responding to nivolumab plus ipilimumab
por: Fuchizawa, Hirotaka, et al.
Publicado: (2021)

Biosimilars in Pemphigus Vulgaris
por: Patil, Sharmila, et al.
Publicado: (2014)

Management of Pemphigus Vulgaris
por: Cholera, Mimansa, et al.
Publicado: (2016)

The Genetics of Pemphigus Vulgaris
por: Vodo, Dan, et al.
Publicado: (2018)

Oral Pemphigus Vulgaris
por: Subadra, K, et al.
Publicado: (2021)

BH3 profiling discriminates the anti-apoptotic status of 5-fluorouracil-resistant colon cancer cells
por: Ishikawa, Kazuma, et al.
Publicado: (2019)

Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma
por: Potluri, Ravi, et al.
Publicado: (2019)

Combination immunotherapy of nivolumab plus ipilimumab in a lung cancer patient with Werner syndrome; a case report
por: Ikematsu, Yuki, et al.
Publicado: (2022)

Subtype transition from pemphigus vulgaris to pemphigus foliaceus
por: Gilkey, Ty, et al.
Publicado: (2022)

Novel use of dupilumab in pemphigus vulgaris and pemphigus foliaceus
por: Jiang, Christina, et al.
Publicado: (2023)

Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma
por: Glutsch, Valerie, et al.
Publicado: (2021)

The best dosage of nivolumab plus ipilimumab combination for melanoma brain metastases
por: Fukumoto, Takeshi, et al.
Publicado: (2022)

Risk of immune-related adverse events associated with ipilimumab-plus-nivolumab and nivolumab therapy in cancer patients
por: Zhou, Shi, et al.
Publicado: (2019)

Pemphigus Vulgaris Presented with Cheilitis
por: Abbas, Zaheer, et al.
Publicado: (2014)

Pemphigus Vulgaris in an Elderly Patient
por: Patvekar, Milind A, et al.
Publicado: (2014)

Rituximab in the Treatment of Pemphigus Vulgaris
por: Zakka, Labib R., et al.
Publicado: (2012)

ACTH Therapy in Pemphigus Vulgaris
por: Chakraborty, A. N., et al.
Publicado: (1953)

Pemphigus vulgaris in a neonate
por: Amer, Yousef Bin, et al.
Publicado: (2007)

Mycobacterium tuberculosis and pemphigus vulgaris
por: Osipowicz, Katarzyna, et al.
Publicado: (2018)

Pemphigus vulgaris - approach and management
por: Popescu, Ioana Adriana, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jg9f1975bllaas0a227el8h9ap